Skip to content

Regenxbio RGNX Net margin

Net margin at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
4.6%+2.4pp
Biogen logo
BiogenBIIB
14.3%-0.8pp
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
16.8%+5.1pp
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
-3,566.6%-3,874pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-90.9%-2.1pp

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Calculated from Regenxbio’s reported figures.

Based on trailing twelve months.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's net margin?
Regenxbio (RGNX) reported net margin of -330.2% in Q1 2026.
How has Regenxbio's net margin changed year-over-year?
Regenxbio's net margin decreased by 228.2% year-over-year, from -100.6% to -330.2%.
What is the long-term trend for Regenxbio's net margin?
Over 5 years (2020 to 2025), Regenxbio's net margin has grown at a 9.6% compound annual growth rate (CAGR), from -72% to -113.8%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.